Implementation of an evidence based smoking cessation strategy (SMOCC) for patients with COPD in primary care

ISRCTN ISRCTN52757029
DOI https://doi.org/10.1186/ISRCTN52757029
ClinicalTrials.gov number NCT00294905
Secondary identifying numbers N/A
Submission date
14/02/2006
Registration date
14/02/2006
Last edited
25/10/2022
Recruitment status
No longer recruiting
Overall study status
Stopped
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr J.E. Jacobs
Scientific

University Medical Centre St. Radboud
Kwaliteit van Zorg
P.O. Box 9101
Nijmegen
6500 HB
Netherlands

Phone +31 (0)24 3615310
Email j.jacobs@kwazo.umcn.nl

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title-
Study objectivesThe large implementation of SMOCC will be more (cost-)effective than the usually applied basic dissemination strategies for guidelines.
Ethics approval(s)Ethics approval received from the local medical ethics committee
Health condition(s) or problem(s) studiedChronic Obstructive Pulmonary Disease (COPD), smoking.
InterventionLarge scale implementation of a combined strategy, aimed at the complete GP practice team (education by consultant at the practice, help with detecting smoking COPD patients, supplying materials for patient education, helpdesk/website, reminders by e-mail and phone) versus usual care.
Intervention typeOther
Primary outcome measurePrimary outcome measures will be biochemically validated smoking abstinence at 12 and 18 months.
Secondary outcome measuresSecondary outcome measures will be counseling contacts and counseling behaviour of professionals and cessation attempts of patients.
Overall study start date01/01/2006
Completion date01/11/2008
Reason abandoned (if study stopped)Participant recruitment issue

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants2700 (open to recruitment)
Key inclusion criteria1. COPD
2. Smoking
3. Age 40 or more
Key exclusion criteria1. Under control of lung specialist
2. Not Dutch-speaking
3. Serious physical or psychiatric comorbidity
4. Age under 40
Date of first enrolment01/01/2006
Date of final enrolment01/11/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

University Medical Centre St. Radboud
Nijmegen
6500 HB
Netherlands

Sponsor information

University Medical Center St. Radboud, Centre for Quality of Care Research (WOK) (The Netherlands)
Not defined

117 KWAZO
P.O. Box 9101
Nijmegen
6500 HB
Netherlands

ROR logo "ROR" https://ror.org/05wg1m734

Funders

Funder type

Research organisation

Netherlands Organisation for Health Research and Development (ZonMw)
Private sector organisation / Other non-profit organizations
Alternative name(s)
Netherlands Organisation for Health Research and Development
Location
Netherlands

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 01/11/2005 Yes No

Editorial Notes

25/10/2022: Internal review.
14/02/2019: Publication reference added.
23/09/2010: Clinicaltrials.gov stated that this trial was terminated by September 2010 due to insufficient recruitment.